Dr. Camilleri’s clinical interests include gastrointestinal motility and function and appetites.
Dr. Camilleri studies gut-based gastrointestinal diseases and diseases in which conditions such as diabetes mellitus, scleroderma and neurological diseases affect the gastrointestinal tract.
The National Institutes of Health awarded Dr. Camilleri several research grants, including several R01 and American Recovery and Reinvestment Act grants.
Dr. Camilleri earned his medical degree from the University of Malta Medical School in Guardamangia and completed his residency at St. Luke’s University Hospital in Guardamangia. He underwent an internal medicine and gastroenterology fellowship at Hammersmith Hospital at the University of London.
More articles on GI & endoscopy:
PENTAX Medical names Dr. Hudson Garrett global chief clinical officer, FDA approves Gilead Sciences’ new chronic HCV drug — 6 GI company key notes
FDA approves Gilead Sciences’ Epclusa for chronic HCV: 4 observations
GI physician leader to know: Dr. Steven Shields of Atrius Health
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
